Spyre Therapeutics, Inc. (SYRE) Earnings
NASDAQ·Healthcare·Biotechnology
$99.38
+0.34%
Mkt Cap $8.34B
EPS — Estimate vs Actual
Mkt Cap
$8.34B
P/E
—
Fwd P/E
—
P/S
92.12
Rev TTM
—
EPS TTM
-$2.19
NASDAQ·Healthcare·Biotechnology
$99.38
+0.34%
Mkt Cap $8.34B
Mkt Cap
$8.34B
P/E
—
Fwd P/E
—
P/S
92.12
Rev TTM
—
EPS TTM
-$2.19